United States Biotechnology & Medical Research

Allogene Therapeutics Inc (ALLO)

Track

Track

Allogene Therapeutics Inc. experienced multiple divestments by corporate leadership during early 2026. Key executives, including the CEO and CFO, executed various sell orders between February and April. These transactions represent the most recent activity, with the final recorded sale occurring on April 21, 2026, exceeding the three-month threshold for current market analysis.
Ticker: ALLO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Allogene Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Yoshiyama Annie SVP, Finance Officer
Transaction date
Sale
Price
119.29
Quantity 16,561 +11.7%
Value US$974,685
3.2
Yoshiyama Annie Officer Officer
Transaction date
Proposed sale
Price
460.93
Quantity 67,786
Value US$349,452
3.4
Beneski Benjamin Machinas Officer Officer
Transaction date
Proposed sale
Price
314.20
Quantity 14,016
Value US$2,776,760
3.4
Beneski Benjamin Machinas SVP, Chief Technical Officer Officer
Transaction date
Sale
Price
2.50
Quantity 2,867 -1.4%
Value US$7,168
2.7
Chang David D President and CEO Executive Director
Transaction date
Sale
Price
2.47
Quantity 47,763 -0.9%
Value US$117,975
3.4
Beneski Benjamin Machinas SVP, Chief Technical Officer Officer
Transaction date
Sale
Price
2.47
Quantity 4,835 -2.4%
Value US$11,942
3.4
Beneski Benjamin Machinas Officer Officer
Transaction date
Proposed sale
Price
2.47
Quantity 4,835
Value US$11,928
2.7
Chang David D Officer Officer
Transaction date
Proposed sale
Price
2.47
Quantity 47,763
Value US$117,827
3.4
Beneski Benjamin Machinas SVP, Chief Technical Officer Officer
Transaction date
Sale
Price
2.60
Quantity 7,132 -3.4%
Value US$18,543
3.4
Beneski Benjamin Machinas Officer Officer
Transaction date
Proposed sale
Price
2.60
Quantity 7,132
Value US$18,541
3.4
Beneski Benjamin Machinas SVP, Chief Technical Officer Officer
Transaction date
Sale
Price
1.73
Quantity 7,549 -3.5%
Value US$13,060
1.4
Douglas Earl Martin SVP, General Counsel Officer
Transaction date
Sale
Price
1.76
Quantity 22,900 -3.9%
Value US$40,304
2.7
Chang David D President and CEO Executive Director
Transaction date
Sale
Price
1.80
Quantity 95,269 -1.8%
Value US$171,484
3.2
Yoshiyama Annie SVP, Finance Officer
Transaction date
Sale
Price
1.72
Quantity 4,167 -3.1%
Value US$7,167
1.9
Parker Geoffrey M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
1.76
Quantity 24,001 -1.9%
Value US$42,242
1.9
Roberts Zachary EVP of R&D Officer
Transaction date
Sale
Price
1.77
Quantity 35,700 -5.8%
Value US$63,189
1.4
EARL DOUGLAS Officer Officer
Transaction date
Proposed sale
Price
1.76
Quantity 22,900
Value US$40,215
1.9
GEOFFREY M PARKER Officer Officer
Transaction date
Proposed sale
Price
1.76
Quantity 24,001
Value US$42,189
1.9
ZACHARY J ROBERTS Officer Officer
Transaction date
Proposed sale
Price
1.77
Quantity 35,700
Value US$63,353
3.2
ANNIE T YOSHIYAMA Officer Officer
Transaction date
Proposed sale
Price
1.72
Quantity 4,167
Value US$7,178
2.7
DAVID CHANG Officer Officer
Transaction date
Proposed sale
Price
1.80
Quantity 243,976
Value US$438,522
3.4
BENJAMIN M BENESKI Officer Officer
Transaction date
Proposed sale
Price
1.73
Quantity 16,823
Value US$29,052
1.9
Roberts Zachary EVP of R&D Officer
Transaction date
Sale
Price
1.56
Quantity 26,269 -4.1%
Value US$40,980
1.9
Roberts Zachary Officer Officer
Transaction date
Proposed sale
Price
1.56
Quantity 26,269
Value US$40,929
3.4
Beneski Benjamin Machinas SVP, Chief Technical Officer Officer
Transaction date
Sale
Price
1.22
Quantity 786 -0.4%
Value US$959
3.4
Beneski Benjamin Machinas Officer Officer
Transaction date
Proposed sale
Price
1.22
Quantity 786
Value US$959
1.9
Parker Geoffrey M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
1.26
Quantity 36,744 -2.8%
Value US$46,169
1.9
Parker Geoffrey M. Officer Officer
Transaction date
Proposed sale
Price
1.26
Quantity 36,744
Value US$46,169
2.7
MESSEMER DEBORAH M. Non-Executive Director
Transaction date
Planned sale
Price
1.42
Quantity 36,885 -25.6%
Value US$52,377
2.7
MESSEMER DEBORAH M. Director Non-Executive Director
Transaction date
Proposed sale
Price
1.42
Quantity 36,885
Value US$52,391
3.2
Yoshiyama Annie SVP, Finance Officer
Transaction date
Sale
Price
1.41
Quantity 9,601 -6.8%
Value US$13,537
3.2
Yoshiyama Annie Officer Officer
Transaction date
Proposed sale
Price
1.41
Quantity 9,601
Value US$13,537
2.7
Chang David D President and CEO Executive Director
Transaction date
Sale
Price
1.96
Quantity 46,668 -0.9%
Value US$91,469
3.4
Beneski Benjamin Machinas SVP, Chief Technical Officer Officer
Transaction date
Sale
Price
1.98
Quantity 5,488 -2.5%
Value US$10,839
3.4
Beneski Benjamin Machinas Officer Officer
Transaction date
Proposed sale
Price
1.97
Quantity 5,488
Value US$10,839
2.7
Chang David D Officer Officer
Transaction date
Proposed sale
Price
1.96
Quantity 46,668
Value US$91,469
2.7
MESSEMER DEBORAH M. Non-Executive Director
Transaction date
Planned sale
Price
2.43
Quantity 13,313 -8.4%
Value US$32,351
2.7
MESSEMER DEBORAH M. Director Non-Executive Director
Transaction date
Proposed sale
Price
2.43
Quantity 13,313
Value US$32,329
1.9
Parker Geoffrey M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
1.73
Quantity 4,361 -0.3%
Value US$7,545
1.9
Roberts Zachary EVP of R&D Officer
Transaction date
Sale
Price
1.70
Quantity 18,832 -2.8%
Value US$32,014
2.7
Chang David D President and CEO Executive Director
Transaction date
Sale
Price
1.68
Quantity 46,003 -0.9%
Value US$77,285
1.4
Douglas Earl Martin SVP, General Counsel Officer
Transaction date
Sale
Price
1.71
Quantity 6,404 -1.1%
Value US$10,951
3.2
MOORE TIMOTHY L. Chief Technical Officer Officer
Transaction date
Sale
Price
1.71
Quantity 14,746 -5.6%
Value US$25,216
1.9
Roberts Zachary Officer Officer
Transaction date
Proposed sale
Price
1.70
Quantity 18,832
Value US$32,014
2.7
Chang David D Officer Officer
Transaction date
Proposed sale
Price
1.68
Quantity 46,003
Value US$77,446
1.4
Douglas Earl Martin Officer Officer
Transaction date
Proposed sale
Price
1.71
Quantity 6,404
Value US$10,951
3.2
MOORE TIMOTHY L. Officer Officer
Transaction date
Proposed sale
Price
1.71
Quantity 14,746
Value US$25,225
1.9
Parker Geoffrey M. Officer Officer
Transaction date
Proposed sale
Price
1.73
Quantity 4,361
Value US$7,545
1.9
Roberts Zachary EVP of R&D Officer
Transaction date
Sale
Price
1.78
Quantity 27,199 -5.3%
Value US$48,414
1.9
Roberts Zachary Officer Officer
Transaction date
Proposed sale
Price
1.78
Quantity 27,199
Value US$48,499
2.7
MESSEMER DEBORAH M. Non-Executive Director
Transaction date
Sale
Price
2.18
Quantity 9,136 -5.5%
Value US$19,916
2.7
MESSEMER DEBORAH M. Director Non-Executive Director
Transaction date
Proposed sale
Price
2.18
Quantity 9,136
Value US$19,954
2.3
Humer Franz B Director Non-Executive Director
Transaction date
Proposed sale
Price
2.30
Quantity 9,221
Value US$21,208
2.3
Humer Franz B Non-Executive Director
Transaction date
Sale
Price
2.16
Quantity 9,221 -2.9%
Value US$19,917
2.3
Humer Franz B Director Non-Executive Director
Transaction date
Proposed sale
Price
2.48
Quantity 9,221
Value US$22,868
1.9
Parker Geoffrey M. Officer Officer
Transaction date
Proposed sale
Price
2.84
Quantity 36,404
Value US$103,501
1.4
Douglas Earl Martin Officer Officer
Transaction date
Proposed sale
Price
2.79
Quantity 28,310
Value US$78,844
2.7
MESSEMER DEBORAH M. Non-Executive Director
Transaction date
Planned sale
Price
2.28
Quantity 18,641 -10.1%
Value US$42,488
2.7
MESSEMER DEBORAH M. Director Non-Executive Director
Transaction date
Proposed sale
Price
2.28
Quantity 18,641
Value US$42,489
2.3
Humer Franz B Non-Executive Director
Transaction date
Sale
Price
2.34
Quantity 11,200 -4.2%
Value US$26,181
2.3
Humer Franz B Director Non-Executive Director
Transaction date
Proposed sale
Price
2.47
Quantity 11,200
Value US$27,716
1.7
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 1,724,137 +inf%
Value US$4,999,997
1.7
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 1,724,137 +inf%
Value US$4,999,997
3.2
MOORE TIMOTHY L. Officer Officer
Transaction date
Proposed sale
Price
3.47
Quantity 17,360
Value US$60,190
2.7
Chang David D Officer Officer
Transaction date
Proposed sale
Price
4.33
Quantity 53,393
Value US$231,065
1.9
Parker Geoffrey M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
3.60
Quantity 190 +0.0%
Value US$683
1.9
Roberts Zachary Officer Officer
Transaction date
Proposed sale
Price
3.17
Quantity 24,690
Value US$78,376
2.7
MESSEMER DEBORAH M. Non-Executive Director
Transaction date
Planned sale
Price
2.70
Quantity 18,640 -23.0%
Value US$50,317
2.7
MESSEMER DEBORAH M. Director Non-Executive Director
Transaction date
Proposed sale
Price
2.70
Quantity 18,640
Value US$50,317
2.2
Mayo Stephen Non-Executive Director
Transaction date
Sale
Price
4.29
Quantity 10,000 -28.3%
Value US$42,855
2.2
Mayo Stephen Director Non-Executive Director
Transaction date
Proposed sale
Price
4.29
Quantity 10,000
Value US$42,855
3.3
Bhavnagri Veer Officer Officer
Transaction date
Proposed sale
Price
4.51
Quantity 39,305
Value US$177,122
3.3
Bhavnagri Veer Officer Officer
Transaction date
Proposed sale
Price
4.85
Quantity 72,995
Value US$354,026
3.0
MOORE ALISON Officer Officer
Transaction date
Proposed sale
Price
5.74
Quantity 531,854
Value US$3,052,842
3.3
Bhavnagri Veer General Counsel Officer
Transaction date
Planned sale
Price
6.85
Quantity 3,000 -0.5%
Value US$20,550
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-23 2026-04-21 S Sale
3.2
Yoshiyama Annie

SVP, Finance

Officer
16,561 +11.7%
119.29
US$974,685 		16,561 +11.7% 119.29 US$974,685
2026-04-21 2026-04-21 PrS Proposed sale
3.2
Yoshiyama Annie

Officer

Officer
67,786
460.93
US$349,452 		67,786 460.93 US$349,452
2026-04-01 2026-04-01 PrS Proposed sale
3.4
Beneski Benjamin Machinas

Officer

Officer
14,016
314.20
US$2,776,760 		14,016 314.20 US$2,776,760
2026-04-02 2026-03-31 S Sale
3.4
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
2,867 -1.4%
2.50
US$7,168 		2,867 -1.4% 2.50 US$7,168
2026-03-18 2026-03-16 S Sale
2.7
Chang David D

President and CEO

Executive Director
47,763 -0.9%
2.47
US$117,975 		47,763 -0.9% 2.47 US$117,975
2026-03-18 2026-03-16 S Sale
3.4
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
4,835 -2.4%
2.47
US$11,942 		4,835 -2.4% 2.47 US$11,942
2026-03-16 2026-03-16 PrS Proposed sale
3.4
Beneski Benjamin Machinas

Officer

Officer
4,835
2.47
US$11,928 		4,835 2.47 US$11,928
2026-03-16 2026-03-16 PrS Proposed sale
2.7
Chang David D

Officer

Officer
47,763
2.47
US$117,827 		47,763 2.47 US$117,827
2026-03-04 2026-03-02 S Sale
3.4
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
7,132 -3.4%
2.60
US$18,543 		7,132 -3.4% 2.60 US$18,543
2026-03-02 2026-03-02 PrS Proposed sale
3.4
Beneski Benjamin Machinas

Officer

Officer
7,132
2.60
US$18,541 		7,132 2.60 US$18,541
2026-02-04 2026-02-02 S Sale
3.4
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
7,549 -3.5%
1.73
US$13,060 		7,549 -3.5% 1.73 US$13,060
2026-02-04 2026-02-02 S Sale
1.4
Douglas Earl Martin

SVP, General Counsel

Officer
22,900 -3.9%
1.76
US$40,304 		22,900 -3.9% 1.76 US$40,304
2026-02-04 2026-02-02 S Sale
2.7
Chang David D

President and CEO

Executive Director
95,269 -1.8%
1.80
US$171,484 		95,269 -1.8% 1.80 US$171,484
2026-02-04 2026-02-02 S Sale
3.2
Yoshiyama Annie

SVP, Finance

Officer
4,167 -3.1%
1.72
US$7,167 		4,167 -3.1% 1.72 US$7,167
2026-02-04 2026-02-02 S Sale
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
24,001 -1.9%
1.76
US$42,242 		24,001 -1.9% 1.76 US$42,242
2026-02-04 2026-02-02 S Sale
1.9
Roberts Zachary

EVP of R&D

Officer
35,700 -5.8%
1.77
US$63,189 		35,700 -5.8% 1.77 US$63,189
2026-02-02 2026-02-02 PrS Proposed sale
1.4
EARL DOUGLAS

Officer

Officer
22,900
1.76
US$40,215 		22,900 1.76 US$40,215
2026-02-02 2026-02-02 PrS Proposed sale
1.9
GEOFFREY M PARKER

Officer

Officer
24,001
1.76
US$42,189 		24,001 1.76 US$42,189
2026-02-02 2026-02-02 PrS Proposed sale
1.9
ZACHARY J ROBERTS

Officer

Officer
35,700
1.77
US$63,353 		35,700 1.77 US$63,353
2026-02-02 2026-02-02 PrS Proposed sale
3.2
ANNIE T YOSHIYAMA

Officer

Officer
4,167
1.72
US$7,178 		4,167 1.72 US$7,178
2026-02-02 2026-02-02 PrS Proposed sale
2.7
DAVID CHANG

Officer

Officer
243,976
1.80
US$438,522 		243,976 1.80 US$438,522
2026-02-02 2026-02-02 PrS Proposed sale
3.4
BENJAMIN M BENESKI

Officer

Officer
16,823
1.73
US$29,052 		16,823 1.73 US$29,052
2026-01-23 2026-01-21 S Sale
1.9
Roberts Zachary

EVP of R&D

Officer
26,269 -4.1%
1.56
US$40,980 		26,269 -4.1% 1.56 US$40,980
2026-01-21 2026-01-21 PrS Proposed sale
1.9
Roberts Zachary

Officer

Officer
26,269
1.56
US$40,929 		26,269 1.56 US$40,929
2025-11-19 2025-11-17 S Sale
3.4
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
786 -0.4%
1.22
US$959 		786 -0.4% 1.22 US$959
2025-11-17 2025-11-17 PrS Proposed sale
3.4
Beneski Benjamin Machinas

Officer

Officer
786
1.22
US$959 		786 1.22 US$959
2025-10-23 2025-10-21 S Sale
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
36,744 -2.8%
1.26
US$46,169 		36,744 -2.8% 1.26 US$46,169
2025-10-21 2025-10-21 PrS Proposed sale
1.9
Parker Geoffrey M.

Officer

Officer
36,744
1.26
US$46,169 		36,744 1.26 US$46,169
2025-06-12 2025-06-10 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
36,885 -25.6%
1.42
US$52,377 		36,885 -25.6% 1.42 US$52,377
2025-06-10 2025-06-10 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
36,885
1.42
US$52,391 		36,885 1.42 US$52,391
2025-04-23 2025-04-21 S Sale
3.2
Yoshiyama Annie

SVP, Finance

Officer
9,601 -6.8%
1.41
US$13,537 		9,601 -6.8% 1.41 US$13,537
2025-04-21 2025-04-21 PrS Proposed sale
3.2
Yoshiyama Annie

Officer

Officer
9,601
1.41
US$13,537 		9,601 1.41 US$13,537
2025-03-18 2025-03-14 S Sale
2.7
Chang David D

President and CEO

Executive Director
46,668 -0.9%
1.96
US$91,469 		46,668 -0.9% 1.96 US$91,469
2025-03-18 2025-03-14 S Sale
3.4
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
5,488 -2.5%
1.98
US$10,839 		5,488 -2.5% 1.98 US$10,839
2025-03-14 2025-03-14 PrS Proposed sale
3.4
Beneski Benjamin Machinas

Officer

Officer
5,488
1.97
US$10,839 		5,488 1.97 US$10,839
2025-03-14 2025-03-14 PrS Proposed sale
2.7
Chang David D

Officer

Officer
46,668
1.96
US$91,469 		46,668 1.96 US$91,469
2025-02-20 2025-02-18 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
13,313 -8.4%
2.43
US$32,351 		13,313 -8.4% 2.43 US$32,351
2025-02-18 2025-02-18 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
13,313
2.43
US$32,329 		13,313 2.43 US$32,329
2025-02-05 2025-02-03 S Sale
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
4,361 -0.3%
1.73
US$7,545 		4,361 -0.3% 1.73 US$7,545
2025-02-05 2025-02-03 S Sale
1.9
Roberts Zachary

EVP of R&D

Officer
18,832 -2.8%
1.70
US$32,014 		18,832 -2.8% 1.70 US$32,014
2025-02-05 2025-02-03 S Sale
2.7
Chang David D

President and CEO

Executive Director
46,003 -0.9%
1.68
US$77,285 		46,003 -0.9% 1.68 US$77,285
2025-02-05 2025-02-03 S Sale
1.4
Douglas Earl Martin

SVP, General Counsel

Officer
6,404 -1.1%
1.71
US$10,951 		6,404 -1.1% 1.71 US$10,951
2025-02-05 2025-02-03 S Sale
3.2
MOORE TIMOTHY L.

Chief Technical Officer

Officer
14,746 -5.6%
1.71
US$25,216 		14,746 -5.6% 1.71 US$25,216
2025-02-03 2025-02-03 PrS Proposed sale
1.9
Roberts Zachary

Officer

Officer
18,832
1.70
US$32,014 		18,832 1.70 US$32,014
2025-02-03 2025-02-03 PrS Proposed sale
2.7
Chang David D

Officer

Officer
46,003
1.68
US$77,446 		46,003 1.68 US$77,446
2025-02-03 2025-02-03 PrS Proposed sale
1.4
Douglas Earl Martin

Officer

Officer
6,404
1.71
US$10,951 		6,404 1.71 US$10,951
2025-02-03 2025-02-03 PrS Proposed sale
3.2
MOORE TIMOTHY L.

Officer

Officer
14,746
1.71
US$25,225 		14,746 1.71 US$25,225
2025-02-03 2025-02-03 PrS Proposed sale
1.9
Parker Geoffrey M.

Officer

Officer
4,361
1.73
US$7,545 		4,361 1.73 US$7,545
2025-01-23 2025-01-21 S Sale
1.9
Roberts Zachary

EVP of R&D

Officer
27,199 -5.3%
1.78
US$48,414 		27,199 -5.3% 1.78 US$48,414
2025-01-21 2025-01-21 PrS Proposed sale
1.9
Roberts Zachary

Officer

Officer
27,199
1.78
US$48,499 		27,199 1.78 US$48,499
2024-12-10 2024-12-09 S Sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
9,136 -5.5%
2.18
US$19,916 		9,136 -5.5% 2.18 US$19,916
2024-12-09 2024-12-09 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
9,136
2.18
US$19,954 		9,136 2.18 US$19,954
2024-12-04 2024-12-06 PrS Proposed sale
2.3
Humer Franz B

Director

Non-Executive Director
9,221
2.30
US$21,208 		9,221 2.30 US$21,208
2024-12-09 2024-12-05 S Sale
2.3
Humer Franz B
Non-Executive Director
9,221 -2.9%
2.16
US$19,917 		9,221 -2.9% 2.16 US$19,917
2024-12-02 2024-12-03 PrS Proposed sale
2.3
Humer Franz B

Director

Non-Executive Director
9,221
2.48
US$22,868 		9,221 2.48 US$22,868
2024-10-21 2024-10-21 PrS Proposed sale
1.9
Parker Geoffrey M.

Officer

Officer
36,404
2.84
US$103,501 		36,404 2.84 US$103,501
2024-08-21 2024-08-21 PrS Proposed sale
1.4
Douglas Earl Martin

Officer

Officer
28,310
2.79
US$78,844 		28,310 2.79 US$78,844
2024-06-20 2024-06-18 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
18,641 -10.1%
2.28
US$42,488 		18,641 -10.1% 2.28 US$42,488
2024-06-18 2024-06-18 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
18,641
2.28
US$42,489 		18,641 2.28 US$42,489
2024-06-03 2024-05-30 S Sale
2.3
Humer Franz B
Non-Executive Director
11,200 -4.2%
2.34
US$26,181 		11,200 -4.2% 2.34 US$26,181
2024-05-29 2024-05-29 PrS Proposed sale
2.3
Humer Franz B

Director

Non-Executive Director
11,200
2.47
US$27,716 		11,200 2.47 US$27,716
2024-05-20 2024-05-16 B Purchase
1.7
Belldegrun Arie
Non-Executive Director
1,724,137 +inf%
2.90
US$4,999,997 		1,724,137 +inf% 2.90 US$4,999,997
2024-05-20 2024-05-16 B Purchase
1.7
Belldegrun Arie
Non-Executive Director
1,724,137 +inf%
2.90
US$4,999,997 		1,724,137 +inf% 2.90 US$4,999,997
2024-04-22 2024-04-22 PrS Proposed sale
3.2
MOORE TIMOTHY L.

Officer

Officer
17,360
3.47
US$60,190 		17,360 3.47 US$60,190
2024-03-14 2024-03-14 PrS Proposed sale
2.7
Chang David D

Officer

Officer
53,393
4.33
US$231,065 		53,393 4.33 US$231,065
2024-03-06 2024-01-30 B Purchase
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
190 +0.0%
3.60
US$683 		190 +0.0% 3.60 US$683
2024-01-22 2024-01-22 PrS Proposed sale
1.9
Roberts Zachary

Officer

Officer
24,690
3.17
US$78,376 		24,690 3.17 US$78,376
2023-12-20 2023-12-18 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
18,640 -23.0%
2.70
US$50,317 		18,640 -23.0% 2.70 US$50,317
2023-12-18 2023-12-18 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
18,640
2.70
US$50,317 		18,640 2.70 US$50,317
2023-08-09 2023-08-07 S Sale
2.2
Mayo Stephen
Non-Executive Director
10,000 -28.3%
4.29
US$42,855 		10,000 -28.3% 4.29 US$42,855
2023-08-07 2023-08-07 PrS Proposed sale
2.2
Mayo Stephen

Director

Non-Executive Director
10,000
4.29
US$42,855 		10,000 4.29 US$42,855
2023-06-29 2023-06-28 PrS Proposed sale
3.3
Bhavnagri Veer

Officer

Officer
39,305
4.51
US$177,122 		39,305 4.51 US$177,122
2023-06-20 2023-06-20 PrS Proposed sale
3.3
Bhavnagri Veer

Officer

Officer
72,995
4.85
US$354,026 		72,995 4.85 US$354,026
2023-06-12 2023-06-12 PrS Proposed sale
3.0
MOORE ALISON

Officer

Officer
531,854
5.74
US$3,052,842 		531,854 5.74 US$3,052,842
2023-02-14 2023-02-13 PlS Planned sale
3.3
Bhavnagri Veer

General Counsel

Officer
3,000 -0.5%
6.85
US$20,550 		3,000 -0.5% 6.85 US$20,550
Explore more

More insider trading research around Allogene Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America